CoChat

Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer’s disease

Open access

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Abstract

Epigenetic dysregulation, which leads to the alteration of gene expression in the brain, is suggested as one of the key pathophysiological bases of ageing and neurodegeneration. Here we found that, in the late-stage familial Alzheimer's disease (FAD) mouse model, repressive histone H3 dimethylation at lysine 9 (H3K9me2) and euchromatic histone methyltransferases EHMT1 and EHMT2 were significantly elevated in the prefrontal cortex, a key cognitive region affected in Alzheimer's disease. Elevated levels of H3K9me2 were also detected in the prefrontal cortex region of post-mortem tissues from human patients with Alzheimer's disease. Concomitantly, H3K9me2 at glutamate receptors was increased in prefrontal cortex of aged FAD mice, which was linked to the diminished transcription, expression and function of AMPA and NMDA receptors. Treatment of FAD mice with specific EHMT1/2 inhibitors reversed histone hyper-methylation and led to the recovery of glutamate receptor expression and excitatory synaptic function in prefrontal cortex and hippocampus. Chromatin immunoprecipitation-sequencing (ChIP-seq) data indicated that FAD mice exhibited genome-wide increase of H3K9me2 enrichment at genes involved in neuronal signalling (including glutamate receptors), which was reversed by EHMT1/2 inhibition. Moreover, the impaired recognition memory, working memory, and spatial memory in aged FAD mice were rescued by the treatment with EHMT1/2 inhibitors. These results suggest that disrupted epigenetic regulation of glutamate receptor transcription underlies the synaptic and cognitive deficits in Alzheimer's disease, and targeting histone methylation enzymes may represent a novel therapeutic strategy for this prevalent neurodegenerative disorder.

Overview

Integrity signals

Registry

Crossref · 10.1093/brain/awy354

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 73 references

Research works printed but not linked: 1

  1. Sperfeld, 1999, FTDP-17: an early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation, Ann Neurol, 46, 708, 10.1002/1531-8249(199911)46:5<708::aid-ana5>3.0.co;2-k · doi:10.1002/1531-8249(199911)46:5<708::aid-ana5>3.0.co;2-k

Cited by

See all 171

Metadata

Authors
Zheng, Y., Liu, A., Wang, Z.-J., Cao, Q., Wang, W., Lin, L., Ma, K., Zhang, F., Wei, J., Matas, E., Cheng, J., Chen, G.-J., Wang, X., & Yan, Z.
Affiliations
  • Capital Medical University (CN)
  • The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
  • Department of Physiology and Biophysics, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA
  • University at Buffalo, State University of New York (US)
  • VA Western New York Healthcare System (US)
  • Department of Neurology, the First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Neurology, Chongqing, P.R.China
Corresponding author
Zheng, Yan
Venue
Brain
Published
2019-01-22
Volume
142
Issue
3
Pages
787-807
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2914500235
Cited by
168
References
73
Citations by year
2026: 12 · 2025: 26 · 2024: 38 · 2023: 25 · 2022: 29 · 2021: 18 · 2020: 13 · 2019: 7
FWCI
11.83
Type
journal article
Language
en
Open access
Locations
  • Brain (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • VA Merit (I01BX001633)
  • National Institutes of Health (R01-AG056060)
  • National Key Research and Development Program of China (2016YFC1306300, 81571038, 81771145)
  • NSFC (81171197, 81220108010)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, EHMT1, G9a, H3K9me2, histone methylation, epigenetic dysregulation, glutamate receptors, AMPA receptors, NMDA receptor, synaptic function, prefrontal cortex, hippocampus, memory impairment, gene transcription
MeSH terms
Alzheimer Disease, Animals, Chromosome Deletion, Cognition, Cognition Disorders, Disease Models, Animal, Hippocampus, Histocompatibility Antigens, Histones, Humans, Lysine, Memory Disorders, Methylation, Mice, Transgenic, Histone-Lysine N-Methyltransferase, Synapses, Prefrontal Cortex, DNA Methylation, Epigenesis, Genetic, Mice, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer’s disease. https://app.cochat.ai/papers/10.1093/brain/awy354
The paper
Zheng, Y., Liu, A., Wang, Z.-J., Cao, Q., Wang, W., Lin, L., Ma, K., Zhang, F., Wei, J., Matas, E., Cheng, J., Chen, G.-J., Wang, X., & Yan, Z. (2019). Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer’s disease. Brain. https://doi.org/10.1093/brain/awy354

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.